Agios Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 05/13/2026 | 5.75 M | $194.69 M | 9.92% | 9.93% |
| FARALLON CAPITAL MANAGEMENT LLC | 05/15/2026 | 5.68 M | $192.29 M | 10.17% | 9.80% |
| STATE STREET CORP | 05/15/2026 | 3.36 M | $113.72 M | 8.26% | 5.80% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 3.20 M | $108.26 M | 6.67% | 5.52% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 2.72 M | $91.88 M | -10.54% | 4.69% |
| ERSTE ASSET MANAGEMENT GMBH | 05/11/2026 | 2.70 M | $80.09 M | -3.57% | 4.67% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 2.68 M | $90.70 M | 45.94% | 4.62% |
| 05/15/2026 | 2.63 M | $89.05 M | 100.00% | 4.54% | |
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 2.61 M | $88.35 M | 3,179.88% | 4.50% |
| 05/08/2026 | 2.61 M | $88.33 M | 100.00% | 4.50% | |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 05/14/2026 | 1.58 M | $53.48 M | 16.18% | 2.73% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 05/15/2026 | 1.49 M | $50.56 M | -12.16% | 2.58% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 1.49 M | $50.37 M | 166,799.10% | 2.57% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.47 M | $49.67 M | 3.85% | 2.53% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 1.34 M | $45.50 M | 17.73% | 2.32% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.31 M | $44.19 M | 0.22% | 2.25% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 1.26 M | $42.49 M | -1.85% | 2.17% |
| GW&K INVESTMENT MANAGEMENT, LLC | 05/13/2026 | 1.21 M | $41.10 M | 0.63% | 2.10% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 1.15 M | $38.94 M | 14.66% | 1.99% |
| MORGAN STANLEY | 05/15/2026 | 967.53 K | $32.73 M | 8.22% | 1.67% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 805.78 K | $27.26 M | -22.07% | 1.39% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 799.16 K | $27.04 M | 0.00% | 1.38% |
| NUVEEN, LLC | 04/30/2026 | 722.35 K | $24.44 M | 142.47% | 1.25% |
| JANE STREET GROUP, LLC | 05/12/2026 | 685.24 K | $23.18 M | -38.88% | 1.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 641.49 K | $21.70 M | 7.30% | 1.11% |
| CITADEL ADVISORS LLC | 05/15/2026 | 619.61 K | $20.96 M | -54.07% | 1.07% |
| SCS CAPITAL MANAGEMENT LLC | 05/11/2026 | 612.85 K | $20.73 M | 2.35% | 1.06% |
| FORESITE CAPITAL MANAGEMENT VI LLC | 05/15/2026 | 525.00 K | $17.76 M | -0.94% | 0.91% |
| NORTHERN TRUST CORP | 05/14/2026 | 509.27 K | $17.23 M | -0.51% | 0.88% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 507.90 K | $17.18 M | -5.83% | 0.88% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/13/2026 | 481.52 K | $16.29 M | -4.55% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 477.03 K | $16.14 M | -1.16% | 0.82% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 450.09 K | $15.23 M | -20.00% | 0.78% |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 450.00 K | $15.22 M | 38.46% | 0.78% |
| MARSHALL WACE, LLP | 05/15/2026 | 448.12 K | $15.16 M | 26.72% | 0.77% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 423.92 K | $14.34 M | 29.16% | 0.73% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 403.59 K | $13.65 M | -13.42% | 0.70% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 403.53 K | $13.65 M | 305.13% | 0.70% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 382.02 K | $12.92 M | 100.00% | 0.66% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 327.46 K | $11.08 M | 34.94% | 0.56% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 298.78 K | $10.11 M | -53.16% | 0.52% |
| KENNEDY CAPITAL MANAGEMENT LLC | 05/13/2026 | 275.46 K | $9.32 M | 319.55% | 0.48% |
| ALGERT GLOBAL LLC | 05/14/2026 | 268.44 K | $9.08 M | -35.19% | 0.46% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 251.64 K | $8.51 M | -16.16% | 0.43% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 250.46 K | $8.47 M | 100.00% | 0.43% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 238.47 K | $8.07 M | 198.68% | 0.41% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 213.60 K | $7.23 M | 0.52% | 0.37% |
| 06/04/2026 | 209.55 K | $7.09 M | 560.24% | 0.36% | |
| SQUAREPOINT OPS LLC | 05/15/2026 | 208.89 K | $7.07 M | 71.55% | 0.36% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 200.06 K | $6.77 M | 100.00% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 343 institutional investors and hedge funds held shares of Agios Pharmaceuticals Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 5.75 M
FARALLON CAPITAL MANAGEMENT LLC: 5.68 M
STATE STREET CORP: 3.36 M
ARMISTICE CAPITAL, LLC: 2.72 M
Erste Asset Management GmbH: 2.7 M
D. E. Shaw & Co., Inc.: 2.68 M
108.74% of Agios Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 82.24 M shares in the last 24 months. This purchase volume represents approximately $2.35 B in transactions.